LILRA3 Antibody (YA7115)(PBS only)

Cat. No.: HY-P87427A: Data Sheet User Guide for Antibodies
FAQs
Technical Support

LILRA3 Antibody (YA7115) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to LILRA3.

For research use only. We do not sell to patients.

Size		Stock
50 μL		Get quote
100 μL		Get quote

* Please select Quantity before adding items.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
Documentation

Description

LILRA3 Antibody (YA7115) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to LILRA3.

Host

Mouse

Molecular Weight

Predicted band size: 47.5kDa;

Species Reactivity

Human

SwissProt ID

Q8N6C8

Immunogen

Purified recombinant fragment of human LILRA3 (AA: 24-168) expressed in E. Coli.

Application &
Dilution Ratio

Application	Dilution Ratio
FC FC: Flow Cytometry	1:200-1:400
ELISA ELISA: Enzyme Linked Immunosorbent Assay	1:10000

Purity	affinity purified.	Conjugation	Non-conjugated
Isotype	IgG1

Appearance

Solution

Formulation

Supplied in PBS, pH 7.4.

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping

Shipping with blue ice.

Background

Function：Acts as a soluble receptor for class I MHC antigens. Binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1 or LILRB2. Binds with high affinity to the surface of monocytes, leading to abolish LPS-induced TNF-alpha production by monocytes

Subcellular Localization：Secreted

Expression：
Tissue_Specificity: Detected in B-cells, and at lower levels in natural killer (NK) cells. Detected in peripheral blood monocytes and lung

Isoforms & Post-Translational Modification：Q8N6C8 has three isomers: Q8N6C8-1: 47472 Da (predicted); Q8N6C8-2: 40357 Da (predicted); Q8N6C8-3: 49187 Da (predicted).
N-glycosylation is required for ligand binding

Synonyms

CD85e, ILT6, LIR4, LILRA3, Leukocyte immunoglobulin-like receptor subfamily A member 3, CD85 antigen-like family member E, Immunoglobulin-like transcript 6, Leukocyte immunoglobulin-like receptor 4, Monocyte inhibitory receptor HM43/HM31, ILT-6, LIR-4

Documentation

User Guide for Antibodies (1077 KB)